Precision Polymer Technologies Co., Ltd. has completed a seed funding round of RMB 10 million. Participants include the Hefei Seed Investment Fund, the Baohe District Science and Technology Innovation Seed Fund, the Anhui Yangtze River Delta Institute for Industrial Innovation, and Luojia Wutong Venture Capital.
Following this funding round, the company will focus on regulatory submissions for pharmaceutical excipients intended for injection and on building its quality system. It will strengthen
For a company that has only recently emerged from a university laboratory, this funding allows us to devote more attention to work that may be less visible but determines whether products can actually be delivered: process development, quality,
From Laboratory Results to Reliably Supplied Products
The precision PEG developed by Precision Polymer differs from conventional polydisperse PEG. It has a defined degree of polymerization and a more clearly specified molecular structure, helping reduce interference from the mixture of chain lengths present in conventional PEG.
There is, however, a substantial gap between obtaining a highly pure laboratory sample and manufacturing it consistently through a stable process.
Where do the raw materials come from? How are process parameters controlled? How are impurities identified? Do residual solvents meet specifications? How long can the product be stored? Are different batches consistent? Each question requires validation and must ultimately be addressed in manufacturing records, analytical methods, and quality specifications.
The company will continue preparing regulatory submissions for its core excipient products and building its quality system. The aim is to ensure that precision PEG can be tested, traced, and reliably supplied against clear specifications, as well as synthesized.
Scaling up precision polymers places demanding requirements on both process control and analysis. A successful laboratory experiment does not guarantee the same outcome in larger equipment. Changes in raw material batches, equipment conditions, processing scale, and operating sequence can all affect the final product.
At this stage, we are therefore prioritizing an understanding of the key issues in
Different drugs, delivery systems, and research applications require different PEG chain lengths and
To address these needs, Precision Polymer will continue developing precision PEG and its derivatives with different chain lengths and end groups and will work with downstream
Precision Polymer was incorporated in October 2025, marking the start of operational implementation of its research commercialization. In January 2026, its precision PEG project received "Research Commercialization Star" recognition at a provincial event. In April 2026, the project was showcased at the Technology Achievement Trade Fair to promote industry collaboration and resource matching. In August 2026, the company completed its seed funding round, bringing together capital and industry resources to accelerate its development.
The company’s history is still short, and this work is only beginning.
Publications and patents demonstrate the novelty of a technology. Turning it into a product that can be used, purchased, and supplied sustainably also requires
Following this funding round, we will continue this foundational work step by step and direct the funding toward products, processes, quality, and customer needs.
We thank the investors, research commercialization platforms, partners, and customers for their trust in and support for Precision Polymer.
Precision Polymer Technologies Co., Ltd.
Precision Polymer | PRECISION PEG